Home/Filings/4/0001209191-18-043395
4//SEC Filing

Gombotz Wayne 4

Accession 0001209191-18-043395

CIK 0001437786other

Filed

Jul 18, 8:00 PM ET

Accepted

Jul 19, 6:03 PM ET

Size

27.5 KB

Accession

0001209191-18-043395

Insider Transaction Report

Form 4
Period: 2018-07-17
Gombotz Wayne
Chief Development Officer
Transactions
  • Disposition to Issuer

    Stock Option (Rt to Buy)

    2018-07-176,5750 total
    Exercise: $31.00Exp: 2025-01-07Common Stock (6,575 underlying)
  • Disposition to Issuer

    Stock Option (Rt to Buy)

    2018-07-1754,0940 total
    Exercise: $19.39Exp: 2026-01-04Common Stock (54,094 underlying)
  • Award

    Stock Option (Rt to Buy)

    2018-07-17+4,2134,213 total
    Exercise: $4.40Exp: 2025-07-17Common Stock (4,213 underlying)
  • Award

    Stock Option (rt to Buy)

    2018-07-17+3,3753,375 total
    Exercise: $4.40Exp: 2025-07-17Common Stock (3,375 underlying)
  • Disposition to Issuer

    Stock Option (Rt to Buy)

    2018-07-178,4250 total
    Exercise: $31.00Exp: 2025-01-07Common Stock (8,425 underlying)
  • Award

    Stock Option (Rt to Buy)

    2018-07-17+26,66726,667 total
    Exercise: $4.40Exp: 2025-07-17Common Stock (26,667 underlying)
  • Disposition to Issuer

    Stock Option (Rt to Buy)

    2018-07-175,9060 total
    Exercise: $19.39Exp: 2026-01-04Common Stock (5,906 underlying)
  • Award

    Stock Option (Rt to Buy)

    2018-07-17+3,2883,288 total
    Exercise: $4.40Exp: 2025-07-17Common Stock (3,288 underlying)
  • Disposition to Issuer

    Stock Option (Rt to Buy)

    2018-07-1740,0000 total
    Exercise: $13.00Exp: 2025-10-30Common Stock (40,000 underlying)
  • Award

    Stock Option (Rt to Buy)

    2018-07-17+30,91130,911 total
    Exercise: $4.40Exp: 2025-07-17Common Stock (30,911 underlying)
Footnotes (9)
  • [F1]The option provided for 1/4th of the shares underlying the option on January 1, 2016 and the remainder of the shares at a rate of 1/36th per month thereafter.
  • [F2]On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 6,575 shares of the issuer's common stock granted to the reporting person on January 7, 2015. In exchange, the reporting person received a replacement option, for 3,288 shares, having an exercise price of $4.40 per share.
  • [F3]The option vests in twenty four (24) equal consecutive monthly installments beginning on August 17, 2018.
  • [F4]On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 8,425 shares of the issuer's common stock granted to the reporting person on January 7, 2015. In exchange, the reporting person received a replacement option, for 4,213 shares, having an exercise price of $4.40 per share.
  • [F5]The option provided for vesting of 37.5% of the option on each of October 30, 2016 and 2017 with the remainder of the shares underlying the option on October 30, 2018.
  • [F6]On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 40,000 shares of the issuer's common stock granted to the reporting person on October 30, 2015. In exchange, the reporting person received a replacement option, for 26,667 shares, having an exercise price of $4.40 per share.
  • [F7]The option provided for vesting of 1/4th of the shares underlying the option on January 4, 2017 and the remainder of the shares underlying the option at a rate of 1/36th per month thereafter.
  • [F8]On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 5,906 shares of the issuer's common stock granted to the reporting person on January 4, 2016. In exchange, the reporting person received a replacement option, for 3,375 shares, having an exercise price of $4.40 per share.
  • [F9]On July 17, 2018, the issuer canceled, pursuant to the issuer's option exchange program, an option for 54,094 shares of the issuer's common stock granted to the reporting person on January 4, 2016. In exchange, the reporting person received a replacement option, for 30,911 shares, having an exercise price of $4.40 per share.

Issuer

IMMUNE DESIGN CORP.

CIK 0001437786

Entity typeother

Related Parties

1
  • filerCIK 0001605922

Filing Metadata

Form type
4
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 6:03 PM ET
Size
27.5 KB